SCHEMBL6926706

SCHEMBL6926706

CC(C)c1cccc(C(C)C)c1N1Cc2ccccc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 3/20 0.41
GABRA1 P14867 2/20 0.40
GABRB2 P47870 2/20 0.40
DPP4 P27487 2/20 0.40
FAAH O00519 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
PTGS1 P23219 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2C P28335 1/20 0.40
GABRB3 P28472 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL456981 0.79 GABRA1 (0.43) ALDH1A1HPGDGABRA1GABRB2DPP4
Hydrochloric Acid SCHEMBL739371 0.78 GABRA1 (0.41) ALDH1A1HPGDGABRA1GABRB2DPP4
Hydrochloric Acid SCHEMBL1727636 0.76 DPP4 (0.40) ALDH1A1HPGDGABRA1GABRB2DPP4
SCHEMBL8990154 0.75 GABRA1 (0.43) HPGDGABRA1GABRB2DPP4FAAH
SCHEMBL14221891 0.74 GABRA1 (0.46) ALDH1A1HPGDGABRA1GABRB2DPP4
SCHEMBL29523444 0.73 DPP4 (0.41) HPGDMAPTGABRA1GABRB2DPP4
SCHEMBL30265954 0.72 FAAH (0.43) ALDH1A1HPGDMAPTGABRA1GABRB2
SCHEMBL15826554 0.72 FAAH (0.43) ALDH1A1HPGDMAPTGABRA1GABRB2
SCHEMBL20408268 0.72 HTR7 (0.43) ALDH1A1MAPTDPP4FAAHNR1H2
SCHEMBL21494571 0.71 POLB (0.50) SMN1; SMN2MAPTDPP4LMNANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-10081666-A None JP disclosed
US-6515129-B1 A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): present invention relates to an aminopeptidase N inhibitor or an angiogenesis inhibitor, modulates production of tumor necrosis ISHIHARA SANGYO KAISHA LTD. (JP) 2003-02-04 US disclosed
US-6429212-B1 AMINOPEPTIDASE N INHIBITOR USED TO TREAT CANCER, TUMORS, AND RETINOPATHY; FEW SIDE EFFECTS; ANGIOGENESIS INHIBITOR ISHIHARA SANGYO KAISHA LTD. (JP) 2002-08-06 US disclosed
JP-H1081666-A PHTHALIMIDE DERIVATIVE OR SALT THEREOF, ITS PRODUCTION AND MEDICINAL COMPOSITION CONTAINING THE SAME ISHIHARA SANGYO KAISHA LTD 1998-03-31 JP disclosed